The Ufm1 conjugation system is a novel ubiquitin-like modification system, consisting of Ufm1, Uba5 (E1), Ufc1 (E2) and poorly characterized E3 ligase(s). RCAD/Ufl1 (also known as KIAA0776, NLBP and Maxer) was reported to function as a Ufm1 E3 ligase in ufmylation (Ufm1-mediated conjugation) of DDRGK1 and ASC1 proteins. It has also been implicated in estrogen receptor signaling, unfolded protein response (UPR) and neurodegeneration, yet its physiological function remains completely unknown. In this study, we report that RCAD/Ufl1 is essential for embryonic development, hematopoietic stem cell (HSC) survival and erythroid differentiation. Both germ-line and somatic deletion of RCAD/Ufl1 impaired hematopoietic development, resulting in severe anemia, cytopenia and ultimately animal death. Depletion of RCAD/Ufl1 caused elevated endoplasmic reticulum stress and evoked UPR in bone marrow cells. In addition, loss of RCAD/Ufl1 blocked autophagic degradation, increased mitochondrial mass and reactive oxygen species, and led to DNA damage response, p53 activation and enhanced cell death of HSCs. Collectively, our study provides the first genetic evidence for the indispensable role of RCAD/Ufl1 in murine hematopoiesis and development. The finding of RCAD/Ufl1 as a key regulator of cellular stress response sheds a light into the role of a novel protein network including RCAD/Ufl1 and its associated proteins in regulating cellular homeostasis. Cell Death and Differentiation (2015) 22, 1922-1934 doi:10.1038/cdd.2015
The Ufm1 (Ubiquitin-fold modifier 1) conjugation system is a novel ubiquitin-like (Ubl) modification system that shares biochemical features with other Ubl systems.
1 Ufm1 modifies its target proteins through a biochemical pathway catalyzed by specific E1 (Uba5), E2 (Ufc1) and E3 enzyme(s) even though the identities of E3 ligases remain mostly elusive. Genetic study from Uba5 knockout (KO) mice has shown that Uba5 is indispensable for embryonic erythropoiesis, highlighting the pivotal role of this novel Ubl system in animal development. 2 Yet its role in adult erythropoiesis and other developmental processes is largely unexplored and the underlying molecular mechanism remains poorly understood.
Regulator of C53 and DDRGK1 (also known as KIAA0776, Ufl1, NLBP and Maxer, referred to as RCAD hereafter) has recently been identified by independent studies as an important regulator of several signaling pathways, including protein ufmylation, NF-κB signaling and unfolded protein response (UPR). [3] [4] [5] [6] [7] [8] [9] Endogenous RCAD forms a complex with two proteins: C53 (also known as LZAP and Cdk5rap3) 5, 6, 10 and DDRGK1 (also designated as C20orf116, Dashurin and UFBP1), 3, 6, 7, 11 and regulates the stability of its binding partners. 5, 6 Intriguingly, Tatsumi et al. 3 found that Ufl1 (same as RCAD) promoted ufmylation of DDRGK1, suggesting that RCAD may function as an E3 ligase for ufmylation of DDRGK1. In line with its role in ufmylation, knockdown of endogenous RCAD resulted in attenuated ufmylation of endogenous Ufm1 targets. 7, 8 More recently, Yoo et al. 12 found that Ufl1-mediated ufmylation of ASC1, a nuclear receptor co-activator, played a crucial role in estrogen receptor signaling and breast cancer development. Nonetheless, the in vivo function of RCAD remains completely unknown.
In this study, we report the establishment of RCAD KO mouse models. Ablation of RCAD leads to impaired embryogenesis and defective hematopoiesis. Our study provides the first genetic evidence for the indispensable role of this important protein in animal development.
Results

RCAD is essential for embryonic erythroid development.
To investigate RCAD's in vivo function, we generated RCAD KO mice. The murine RCAD gene is located in chromosome 4 and consists of 19 exons (Supplementary Figure 1a) . Based upon the 'knockout first' strategy, 13 a gene trap cassette flanked by two FRT sites was inserted into the intron between exons 6 and 7 and followed by floxed exon 7, generating a RCAD Trap-F allele ( Figure 1a) . Insertion of the gene trap was confirmed by Southern blotting and genomic PCR ( Supplementary Figures 1c and d) . Disruption of RCAD expression was confirmed by the complete absence of RCAD protein in the embryos with homozygous trapped alleles ( Figure 1b) . Therefore, the mice with homozygous trapped alleles (RCAD Trap-F/Trap-F ) were designated as RCAD −/− or RCAD KO mice.
Among 85 adult mice, we failed to obtain RCAD −/− animals, whereas 29 RCAD +/+ and 56 RCAD +/ − mice were born healthy and appeared normal, indicating a possible embryonic lethality caused by loss of RCAD. By analyzing the embryos of timedpregnant mice, we found that most RCAD −/− embryos could survive until E11.5, but some died as early as E10.5 ( Figure 1c) . RCAD −/− embryos appeared anemic and smaller than their wild-type (WT) and heterozygous littermates ( Supplementary  Figure 1e) , and RCAD −/− fetal livers were also smaller ( Figure 1d ). Additionally, there were a high number of abnormal multinucleated erythrocytes in RCAD −/− embryos (Figures 1e-g ), a phenotype reminiscent of Uba5 null embryos. 2 The numbers of erythroid colony-forming units (CFU-Es) and more immature erythroid burst-forming units (BFU-Es) from fetal livers (E11.5) were significantly lower in RCAD −/− fetal livers (Figure 1h ), suggesting impaired development of erythroid progenitors. Accordingly, the genes associated with the erythroid lineage, including ε-globin, βH1-globin and transcription factors GATA-1/FOG-1 and Klf1, were markedly underexpressed in RCAD −/− fetal livers (Figure 1i ). Collectively, our results strongly suggest that RCAD is essential for embryonic erythropoiesis, development and survival.
RCAD loss causes severe anemia and cytopenia in adult mice. To further investigate the in vivo role of RCAD in hematopoiesis, we generated inducible conditional KO (CKO) mice of RCAD via a two-step procedure: (1) removal of the gene trap cassette by crossing RCAD Trap-F/+ mice with FLPo deleter mice; and (2) subsequent introduction of tamoxifen (TAM)-inducible Cre recombinase CreERT2 under the ROSA26 promoter. As shown in Figure 2a , TAM administration in RCAD Figure 2a) . Interestingly, ufmylation of endogenous targets was significantly attenuated in RCAD-deficient BM cells (Supplementary Figure 2b) .
Although WT:ROSA26-CreERT2 and RCAD F/F mice were fairly normal after TAM administration (data not shown), TAMinduced ablation of RCAD in RCAD F/F :CreERT2 mice led to substantial loss of body weight and ultimately animal death around 3 weeks after initial TAM treatment ( Figure 2b) . As indicated by color of blood and BM as well as the complete blood count (CBC), RCAD-deficient mice exhibited severe anemia and pancytopenia, which may be the primary cause for animal death. The major indices for erythrocytes, including RBC (red blood cell) count, Hgb (hemoglobin) content and HCT (hematocrit), were significantly lower in RCAD-deficient mice (Figure 2c ). Furthermore, total white blood cell counts, including lymphocytes, granulocytes, monocytes, as well as platelet counts were also dramatically decreased in RCAD-deficient mice (Figure 2c ). This result provides the first genetic evidence for the indispensable role of RCAD in adult hematopoiesis. :CreERT2) (n = 5) when RCAD-deficient mice became moribund and/or lost 20% of body weight after TAM injection (2-3 weeks post-TAM treatment). The blood samples were subjected to CBC counting. The mice used in this experiment were~8-week-old male mice. Female RCAD-deficient mice exhibited the similar phenotype (data not shown). GRA, granulocyte; HCT, hematocrit; Hgb, hemoglobin; LYM, lymphocyte; MON, monocyte; PLT, platelet; RBC, red blood cell; WBC, white blood cell (Figure 3a) . By contrast, the percentage of GMPs (18.8 ± 8.06% versus 81.77 ± 2.59%) was substantially increased in RCAD-deficient BM, while the percentage of Pre GMs (13.47 ± 1.65% versus 7.46 ± 1.68%) was modestly decreased (Figures 3a and b) . Accordingly, the total cell numbers of erythroid progenitors in RCAD-deficient BM were significantly decreased, but the number of GMPs was dramatically elevated (Figure 3c ). Quantitative RT-PCR analysis showed that the genes associated with the erythroid lineage such as Gata-1, Fog-1, Klf1 and Scl, were underexpressed in BM and sorted myeloerythroid precursor cells, but expression of Pu.1, a gene associated with myeloid lineage, was either upregulated in BMs or not altered in sorted cells (Figures 3d and e) . In contrast to elevation of GMPs in BM, the numbers of mature myeloid cells (granulocytes and monocytes) in peripheral blood were decreased (Figure 2c ), indicating a possible developmental defect in myeloid lineages. Indeed, the numbers of CFU-Gs, CFU-Ms and CFU-GMs in RCAD-deficient BM were significantly decreased (Supplementary Figure 3) . Taken together, these results suggest that RCAD plays a critical role in multiple stages of erythropoiesis including progenitor development and terminal differentiation as well as development of myeloid lineages.
RCAD is essential for HSC function in a cell-autonomous manner. RCAD-deficient mice also exhibited a severe cytopenia in peripheral blood (Figure 2c Figure 7) . p53 is a major molecular sensor of cellular stresses that promotes cell cycle arrest, senescence and cell death. [15] [16] [17] [18] [19] It also has a pivotal role in maintaining homeostasis of HSCs and progenitor cells under normal and stress conditions. 20 We examined p53 activation in RCAD-deficient cells. As shown in Figure 5d , expression of two p53 targets, p21 WAF1 and Bax, 21, 22 was substantially upregulated in 4-OHT-treated HSCs, while the level of p53 mRNA was not significantly changed ( Figure 5d ). The protein levels of p53 and its target p21 WAF1 were also elevated in 4-OHT-treated HSCs (Figure 5e ). Furthermore, phosphorylation of H2A.X was substantially increased in both RCAD-deficient BM cells (in vivo, Figure 5f ) and HSCs (in vitro, Figure 5g ), indicating that loss of RCAD elicits DNA damage response and p53 activation. To further interrogate the role of p53, we took advantage of pifithrin-α (PFT-α), a cell-permeable p53 inhibitor that blocks p53 transcriptional activity and reduces the side effects of chemotherapy. 23 The presence of PFT-α (10 μM) itself somewhat caused slower cell proliferation and cell death of HSCs (data not shown and Figure 5i ), probably due to its inhibitory activity toward other signaling pathways such as heat shock response, glucocorticoid signaling and p73 pathway. 24, 25 Nonetheless, treatment with PFT-α significantly blocked upregulation of p21 and Bax (Figure 5h ) as well as cell death (Figure 5i) induced by RCAD loss. These results suggest that aberrant p53 activation may cause apoptosis and cell cycle arrest in RCAD-deficient HSCs.
RCAD deficiency leads to elevated ER stress and activation of the unfolded protein response (UPR). It has been reported that RCAD mainly localizes to the endoplasmic reticulum (ER) membrane and plays a protective role in ER stress-induced apoptosis, and depletion of RCAD readily activates the UPR in osteosarcoma cells. 7, 8 TAM-induced depletion of RCAD in BM cells led to up-expression of ER chaperones Grp78 and ERdj4 (Figure 6a ), elevation of phosphorylation of eIF2α (Figure 6b ), and Xbp-1 mRNA alternative splicing (Figure 6c ), all of which are the markers for elevation of ER stress and activation of the UPR. Furthermore, cell death genes including Bax, Noxa, Puma and DR5 were also upregulated by RCAD depletion (Figure 6d ). These results suggest that RCAD functions as a cytoprotective role in cell stress response, which is consistent with previous results in other cells. 7, 8 RCAD deficiency impairs autophagic degradation. Given the cytoprotective function of autophagy in cellular stress response, we also examined autophagy in RCAD-deficient cells. Interestingly, LC3-II, a lipidated form of LC3, and p62, an autophagic substrate, were significantly accumulated in RCAD-depleted BM cells (Figure 7a ) and HSCs (Figure 7b) , while their mRNA levels remained unchanged (data not shown). The increase of both LC3-II and p62 indicates that RCAD depletion may impede autophagic degradation rather than initiation of autophagy. Previous studies have shown that deficiency in autophagy causes accumulation of reactive oxygen species (ROS) and mitochondrial mass in HSCs. 26, 27 In TAM-treated RCAD CKO mice, we observed the increase of ROS (DCF-DA staining, Figure 7c 
Discussion
We report here that RCAD is essential for murine hematopoiesis in both embryonic and adult stages. Ablation of RCAD caused anemia, cytopenia and animal death (Figures 1 and 2) . RCAD-deficient HSCs failed to compete with WT cells ( Figure 5 ). Loss of RCAD led to elevated ER stress and activation of the UPR in vitro and in vivo ( Figure 6 ). Additionally, RCAD deficiency caused impairment of autophagic degradation that led to accumulation of ROS and mitochondrial mass, aberrant p53 activation and apoptosis of HSCs ( Figure 7 ). Taken together, our findings establish the essential role of RCAD in murine development and provide a critical insight into the molecular and cellular mechanism of RCAD function. Recent studies have demonstrated that RCAD functions as a Ufm1 E3 ligase to promote ufmylation of DDRGK1 and ASC1. 3, 12 Interestingly, Uba5 and RCAD KO mice exhibit broad phenotypic similarities. First, inactivation of either gene led to defective embryonic erythropoiesis and lethality ( Figure 1 and Tatsumi et al.
2 ). Second, Uba5 deficiency causes impaired development of MEPs, but not GMPs, in fetal livers, while conditional deletion of RCAD in adult mice resulted in defective development of MegE progenitors but not GMPs (Figure 3 and Tatsumi et al.
2 ). Third, a high number of multinucleated erythroid cells were found in both Uba5 and RCAD KO embryos ( Figure 1 and Tatsumi et al.
2 ). These phenotypic similarities between Uba5 and RCAD KO mice strongly suggest that they may function in the similar cellular process(es) or signaling pathways during erythroid development. Intriguingly, a genome-wide association study has identified one single-nucleotide polymorphisms (rs11697186) in DDRGK1 gene that is strongly associated with anemia and thrombocytopenia in peggylated interferon and ribavirin therapy for chronic hepatitis C patients, which provides clinical evidence for possible involvement of DDRGK1 in regulation of hematopoiesis. 28 One of our key findings is that RCAD deficiency causes elevated ER stress and activation of the UPR in hematopoietic cells (Figure 6 ), a result that is consistent with a previous report on the cytoprotective role of the Ufm1 system in ER stress-induced apoptosis of pancreatic β-cells. 7 The UPR is a highly coordinated program that facilitates protein folding, processing, export and degradation of proteins during cellular response to ER stress. Although the UPR serves as a cytoprotective mechanism to restore ER homeostasis, persistent activation of the UPR leads to cell death and tissue damage. 29 It was reported that HSCs and other progenitor cells exhibit distinct cellular response to extracellular ER stressors, and the UPR has a critical role in governing the integrity of HSC pool during stress. 30 Therefore, it is plausible that RCAD and the Ufm1 system are important players in modulating HSC's response to ER stress.
We also found that RCAD depletion impeded autophagic flux (Figure 7 ). Autophagy plays a pivotal role in hematopoiesis, including maintenance of HSC functions, 26, 31, 32 lymphocyte survival 33, 34 and erythroid cell maturation. 27, 35 Loss of either FIP200 or ATG7, two essential components for initiation of autophagosome formation, leads to accumulation of mitochondrial mass and ROS in HSCs, resulting in impaired HSC function. 26, 31 In agreement with its role in autophagy, loss of RCAD also led to increased mitochondrial mass, accumulation of ROS and impaired HSC function (Figure 7) . Interestingly, erythroid progenitors, but not Pre GMs and GMPs, appeared to be more susceptible to RCAD deficiency, indicating that erythroid progenitors are more dependent on the cytoprotective function of autophagy (Figure 3 ). This result is consistent with previous reports demonstrating that FOXO3A-and GATA-1-driven pro-autophagy gene programs function as a cytoprotective mechanism in HSCs and erythroid progenitors. 32, 36 However, RCAD KO mice appear to exhibit more severe phenotype comparing to either ATG7 or FIP200 KO mice. RCAD KO embryos usually died around E11.5. In comparison, FIP200 KO embryos can survive until E15.5, 37 while KO of ATG7 leads to neonatal lethality. 38 The phenotypic differences of these KO mice may reflect distinct roles of these proteins in cellular stress response. First, RCAD depletion results in elevated ER stress and UPR activation that was not reported in ATG7 or FIP200 KO mice. 26, 31 Additionally, we did not observe significant upregulation of UPR genes in BM cells treated with lysosomal inhibitor CQ (data not shown), indicating that inhibition of autophagy does not necessarily leads to ER stress in BM cells. Second, while FIP200 and ATG7 regulate the early stage of autophagy, RCAD appears to be involved in the late stage of autophagy. It is plausible that accumulation of excessive and defective autophagosomes/ autolysomes (e.g., in RCAD KO cells) is more detrimental to cells than lack of basal autophagy (e.g., in Atg7 KO cells). Young et al. 39 showed that autophagosomal membrane serves as a platform for an intracellular death-induction signaling complex (iDISC) to trigger caspase activation and apoptosis when MEFs were treated with SKI-I, a pansphingosine kinase inhibitor, and bortezomib, a proteasome inhibitor. Therefore, it is likely that a combination of ER stress and defective autophagy may contribute to the enhanced severity of RCAD KO mice when comparing with ATG7 and FIP200 KO mice.
The remaining question is how RCAD is involved in regulation of ER stress response and autophagic degradation. Given the fact that RCAD and its associated proteins are mostly associated with the subcellular membranes, it is plausible that RCAD and the Ufm1 system may constitute a novel protein network broadly involved in regulation of membrane dynamics and homeostasis. The genetic study in Caenorhabditis elegans indicates that the Ufm1 system is involved in regulation of the UPR. 40 Furthermore, C53 protein, one of RCAD downstream targets, has been shown to be a microtubule-binding protein. 41 C53 KO leads to cell cycle defects and early embryonic lethality, 42 and depletion of C53 protein in tissue culture cells dramatically decreases the numbers of several types of intracellular vesicles (our unpublished observation). Therefore, we postulate that the RCAD/C53/DDRGK1 complex has an important role in regulation of intracellular vesicle trafficking. Depletion of either component of the complex may cause disruption of vesicle trafficking from the ER, thereby resulting in elevated ER stress. Additionally, since the ER is one of the primary sources of the autophagosome membranes, 43, 44 it is plausible that disruption of the ER homeostasis upon RCAD depletion also causes impairment of autophagic flux. Further studies will elucidate this regulatory mechanism of cellular homeostasis mediated by RCAD and the Ufm1 conjugation system. To generate CKO mice, we crossed RCAD Trap-F/+ mice with FLPo deleter mice (B6(C3)-Tg(Pgk1-FLPo)10Sykr/J, The Jackson Laboratory, Bar Harbor, ME, USA) to remove the gene trap cassette. The floxed RCAD mice were crossed with ROSA26-CreERT2 mice (B6.129-Gt(ROSA)26Sorotm1(cre/ERT2) Tyj4/J, The Jackson Laboratory) in which CreERT2 was inserted into ROSA26 locus. Cre-mediated deletion of RCAD was induced by tamoxifen administration. Tamoxifen (20 mg/ml in corn oil, Sigma) was administrated by 5-day IP injection with an approximate dose of 75 mg tamoxifen/kg body weight. All animal procedures were approved by IACUC of Georgia Regents University.
The following primers were used for PCR genotyping of RCAD KO embryos and mice: 5′-1 (AAGACCATTGACTTACATACTTGA), 5′-2 (CACAACGGGTTCTTCTG TTAG TCC) and 5′-3: (ACCCTGTACACGTACCATTTCTAG). ;ROSA-CreERT2 mice (CD45.2) were isolated, mixed with BM cells from CD45.1 mice in a 1 : 1 ratio (1 × 10 6 cells total), and subsequently injected into the retro-orbital venous sinus of anesthetized recipient mice (five mice per group). After a 4-week recovery period, tamoxifen was administered in 5 consecutive days. Donor cell engraftment was monitored by flow cytometry of the blood samples from tail veins in a 2-week interval using lineage markers. After 3 weeks of tamoxifen injection, BM cells were subjected to flow analysis.
CBC counting and colony formation assays of BFU-Es, CFU-Es, CFU-Gs, CFU-Ms and CFU-GMs. Fetal liver cells (5000 cells) were plated in one ml of serum-free methylcellulose and IMDM (M3234, STEMCELL Technologies, Vancouver, BC, Canada) supplemented with 10% fetal bovine serum. For CFU-Es, cells were cultured for 3 days in the presence of hEpo (2 units/ml, Epogen, Amgen, Thousand Oaks, CA, USA) and stained with benzidine dihydrochloride, and the number of colonies is scored. For BFU-Es, cells were cultured in the presence of hEpo (2 units/ml) and mSCF (100 ng/ml, Peprotech, Rocky Hill, NJ, USA) for 7 days, stained and scored. For CFU-Gs, CFU-Ms and CFU-GMs, BM cells (20 000) were cultured in M3434 (STEMCELL Technologies) for 12 days, and the numbers of the colonies were manually counted.
CBC counts of blood samples from adult mice were analyzed by Laboratory Solutions, Inc. (North Augusta, SC) and in-house Horiba ABX Micro S60 analyzer (HORIBA Medical, Irvine, CA, USA).
In vitro culture of HSC and progenitor cells. Sorted BM HSC and myeloerythroid progenitor cells were cultured in IMDM supplemented with 10% fetal bovine serum, hEpo (2 units/ml, Amgen), mSCF (100 ng/ml, Peprotech), mIL-3 (10 ng/ml, Peprotech), Dexamethasone (1 μM, Sigma) and IGF-1 (100 ng/ml, Invitrogen). Deletion of RCAD was induced by addition of 4-hydroxytamoxifen (1 μM, Sigma).
Flow cytometry analysis and cell sorting. Freshly isolated BM cells were suspended in PBS with 1% fetal bovine serum and stained with BV510-Sca-1 (Biolegend, San Diego, CA), APC780-c-Kit (eBioscience, San Diego, CA, USA), PE-Cy7-CD150 (Biolegend), Alexa700-CD16/32 (eBioscience), PE-IL-7R (BD Biosciences, San Jose, CA, USA), APC-CD41 (BD Biosciences), BV650-CD105 (Biolegend), FITC-CD71 (BD Biosciences), BV421-TER119 (Biolegend), and PerCP-Cy5.5 conjugated lineage markers including CD4, CD8, CD3, CD5, Gr-1, CD11b, CD19 and B220 (BD Biosciences). The samples were analyzed using BD LSR II SORP and Diva 7.0 software (GRU Cancer Center Flow Cytometry Facility). For competitive repopulation assays, BV421-CD45.2 (Biolegend) was used to substitute BV421-TER119. Cell sorting of HSCs and progenitor cells was performed using BD FACSAria II SORP.
Measurement of ROS and mitochondrial mass. After staining of specific cell surface markers, BM cells were then stained by MitoTracker-Green (50 nM), or by DCF-DA (2′,7′-dichlorofluorescin diacetate, 10 μM) for 30 min at 37°C and analyzed immediately by flow cytometry.
Cell cycle analysis. Single cells (1-2 × 10 6 ) were fixed in 70% methanol at − 20°C overnight, and washed with PBS for three times. Cells were then suspended in 400 μl PBS containing 20 μg/ml propidium iodine (PI) and 200 μg/ml of RNase A, and incubated at 37 o C for 2 h. Cell cycle profile was analyzed using BD LSR II SORP and ModFIT LT v4.0. 
